Sionna Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing novel medicines for cystic fibrosis, will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference. The event is scheduled for June 11, 2025, at 8:00 a.m. ET in Miami, Florida. A live webcast and replay of the presentation will be available on the company's website.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9460055-en) on June 03, 2025, and is solely responsible for the information contained therein.